Sighture Medical today announced a strategic deployment of its premium GAITNOVATE-III Biomechanical Analysis Systems at West China Hospital of Sichuan University – China's #1 ranked hospital for 12 consecutive years. This partnership marks Sighture's official entry into the nation's most prestigious medical institutions following the system's commercial launch last quarter.
Key Significance
Clinical Validation: Adoption by Asia's largest hospital (8,000+ beds) confirms GAITNOVATE-III's technical leadership
Advanced Capabilities: Comprehensive static + dynamic assessment with 12,288 high-density sensors (800Hz scanning)
Strategic Milestone: Represents Sighture's penetration into China's top-tier academic medical centers
"This collaboration with West China Hospital exemplifies our commitment to advancing precision diagnostics," stated CEO Yang Yupeng. "Their selection of GAITNOVATE-III demonstrates confidence in our ability to deliver research-grade biomechanical data for demanding clinical environments."
System Implementation
Deployment: Rehabilitation Medicine Department & Orthopedic Research Center
Applications: ◦ Post-surgical gait rehabilitation protocols ◦ Sports injury biomechanics studies ◦ Diabetic foot ulcer risk stratification
Integration: Seamless connectivity with hospital's EMR system
As China's premier academic medical center handling 5.5 million annual patient visits, West China Hospital will utilize GAITNOVATE-III's integrated assessment capabilities to establish standardized biomechanical evaluation pathways. Sighture's engineering team will provide on-site training and joint research support through 2026.
About Sighture Medical
Pioneering sensor-based medical devices since 2016. ISO 13485-certified with 29 patents across ophthalmology robotics and biomechanics. GAITNOVATE systems now deployed in 17 provinces.
English 
